Free Trial
NASDAQ:NRC

National Research (NRC) Stock Price, News & Analysis

National Research logo
$11.68 +0.23 (+2.01%)
Closing price 04:00 PM Eastern
Extended Trading
$11.70 +0.02 (+0.17%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About National Research Stock (NASDAQ:NRC)

Advanced

Key Stats

Today's Range
$11.20
$11.77
50-Day Range
$11.45
$16.20
52-Week Range
$9.76
$21.64
Volume
102,889 shs
Average Volume
94,441 shs
Market Capitalization
$269.39 million
P/E Ratio
15.37
Dividend Yield
4.11%
Price Target
N/A
Consensus Rating
Sell

Company Overview

National Research Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

NRC MarketRank™: 

National Research scored higher than 54% of companies evaluated by MarketBeat, and ranked 193rd out of 327 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of National Research is 15.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.22.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of National Research is 15.37, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 26.17.

  • Price to Book Value per Share Ratio

    National Research has a P/B Ratio of 8.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about National Research's valuation and earnings.
  • Percentage of Shares Shorted

    3.52% of the float of National Research has been sold short.
  • Short Interest Ratio / Days to Cover

    National Research has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in National Research has recently decreased by 0.71%, indicating that investor sentiment is improving.
  • Dividend Leadership

    National Research is a leading dividend payer. It pays a dividend yield of 4.18%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    National Research does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of National Research is 63.16%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about National Research's dividend.
  • Percentage of Shares Shorted

    3.52% of the float of National Research has been sold short.
  • Short Interest Ratio / Days to Cover

    National Research has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in National Research has recently decreased by 0.71%, indicating that investor sentiment is improving.
  • News Sentiment

    National Research has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for National Research this week, compared to 2 articles on an average week.
  • Search Interest

    5 people have searched for NRC on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, National Research insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 8.10% of the stock of National Research is held by insiders.

  • Percentage Held by Institutions

    47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about National Research's insider trading history.
Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NRC Stock News Headlines

Mercy Earns National Honor for Excellence in Patient Experience
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
NRC Health Honors 2025 Leaders in Patient Experience and Loyalty
See More Headlines

NRC Stock Analysis - Frequently Asked Questions

National Research's stock was trading at $17.64 at the beginning of the year. Since then, NRC stock has decreased by 33.8% and is now trading at $11.68.

National Research Corporation (NASDAQ:NRC) issued its quarterly earnings data on Monday, July, 28th. The company reported $0.28 earnings per share for the quarter. The firm had revenue of $34.04 million for the quarter. National Research had a net margin of 12.78% and a trailing twelve-month return on equity of 83.52%.
Read the conference call transcript
.

National Research subsidiaries include these companies: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada.

National Research's top institutional shareholders include Exchange Traded Concepts LLC (0.08%) and CWM LLC (0.05%). Insiders that own company stock include Amandla Mk Trust, Patrick E Beans, Kevin R Karas, Jona S Raasch and Jordan Nicole Freeman.
View institutional ownership trends
.

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
7/28/2025
Record date for 10/10 Dividend
9/26/2025
Ex-Dividend for 10/10 Dividend
9/26/2025
Dividend Payable
10/10/2025
Today
10/16/2025
Next Earnings (Estimated)
10/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
BUSINESS INFO SVC
Sub-Industry
Business Services
Current Symbol
NASDAQ:NRC
CIK
70487
Employees
490
Year Founded
1981

Profitability

EPS (Trailing Twelve Months)
$0.76
Trailing P/E Ratio
14.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$24.78 million
Net Margins
12.78%
Pretax Margin
17.44%
Return on Equity
83.52%
Return on Assets
18.05%

Debt

Debt-to-Equity Ratio
3.61
Current Ratio
0.70
Quick Ratio
0.70

Sales & Book Value

Annual Sales
$140.31 million
Price / Sales
1.85
Cash Flow
$1.31 per share
Price / Cash Flow
8.63
Book Value
$1.36 per share
Price / Book
8.30

Miscellaneous

Outstanding Shares
23,064,000
Free Float
21,196,000
Market Cap
$260.23 million
Optionable
Optionable
Beta
0.41

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:NRC) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners